Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Takahito Suto, Yukio Yonemoto, Koichi Okamura, Hideo Sakane, Kimihiko Takeuchi, Yasuyuki Tamura, Tetsuya Kaneko, Keio Ayabe & Hirotaka Chikuda. (2019) The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis. Modern Rheumatology 29:5, pages 775-781.
Read now
Read now
Tomohiro Kubota, Syuji Takei, Masaki Shimizu, Junko Yasumura, Yasuo Nakagishi, Toshitaka Kizawa, Masato Yashiro, Hiroyuki Wakiguchi, Yuichi Yamasaki & Yoshifumi Kawano. (2018) Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. Modern Rheumatology 28:5, pages 826-831.
Read now
Read now
Ayaka Yoshikawa, Shuzo Yoshida, Yuko Kimura, Nao Tokai, Yohei Fujiki, Takuya Kotani, Yoko Matsumura, Tohru Takeuchi & Shigeki Makino. (2018) Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study. Modern Rheumatology 28:2, pages 227-234.
Read now
Read now
Karen J. Wedekind, Kevin J. Ruff, Cindy A. Atwell, Joseph L. Evans & Alison M. Bendele. (2017) Beneficial effects of natural eggshell membrane (NEM) on multiple indices of arthritis in collagen-induced arthritic rats. Modern Rheumatology 27:5, pages 838-848.
Read now
Read now
Ryosuke Kamei, Masanori Kono, Yukiko Iwasaki, Hirofumi Shoda, Kanae Kubo, Keishi Fujio & Kazuhiko Yamamoto. (2017) Iguratimod-induced acute interstitial pneumonia with hypogammaglobulinemia in a rheumatoid arthritis patient. Modern Rheumatology Case Reports 1:2, pages 54-59.
Read now
Read now
Articles from other publishers (7)
Liuting Zeng, Qi He, Ying Deng, Yuwei Li, Junpeng Chen, Kailin Yang, Yanfang Luo, Anqi Ge, Xiaofei Zhu, Zhiyong Long & Lingyun Sun. (2023) Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials. Frontiers in Pharmacology 14.
Crossref
Crossref
Yuji Nozaki, Motohiro Oribe, Daisuke Tomita, Tetsu Itami, Shinya Hayashi, Toshihisa Maeda, Koji Fukuda, Ryosuke Kuroda, Keiko Funahashi, Tsukasa Matsubara, Koji Kinoshita & Itaru Matsumura. (2022) Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching. Modern Rheumatology.
Crossref
Crossref
Liuting Zeng, Ganpeng Yu, Kailin Yang, Wensa Hao & Hua Chen. (2022) The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial. Frontiers in Pharmacology 12.
Crossref
Crossref
Sha Liu, Li-Ping Song, Rong-Bin Li, Le-Heng Feng & Hui Zhu. (2021) Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway. World Journal of Clinical Cases 9:10, pages 2181-2191.
Crossref
Crossref
Wei Jiang, Lingshu Zhang, Yi Zhao, Xiong He, Chunrong Hu & Yi Liu. (2020) The efficacy and mechanism for action of iguratimod in primary Sjögren’s syndrome patients. International Ophthalmology 40:11, pages 3059-3065.
Crossref
Crossref
Jie Li, Jun Bao, Jian Zeng, Aizhu Yan, Chunqiu Zhao & Qiang Shu. (2019) Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. Bone Research 7:1.
Crossref
Crossref
Feng Xiao, Feng Zhang, Ling-ling Zhang & Wei Wei. (2017) A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers. European Journal of Clinical Pharmacology 74:1, pages 69-77.
Crossref
Crossref